# Nizar M. Tannir

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nizar-m-tannir/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,164 |
| Field | Renal cell carcinoma treatment |
| h-index | 84 |
| i10-index | 338 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5058115259 |
| ORCID iD | https://orcid.org/0000-0001-5559-8060 |
| Works | 1,075 |

## Researcher papers

- [Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-plus-ipilimumab-versus-sunitinib-in-advanced-renal-cell-carcinoma/)
- [Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer](https://scholariq.org/papers/platinum-based-chemotherapy-for-variant-castrate-resistant-prostate-cancer/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.